Comprehensive Prostate Cancer Care
From Advanced Screening to Personalized Treatment
From Advanced Screening to Personalized Treatment
The Prostate Cancer Institute of America is dedicated exclusively to providing comprehensive, personalized prostate cancer care—from advanced screening and early detection to innovative treatment. Using the latest imaging, genetic testing, and minimally invasive techniques, we help patients make informed decisions and achieve the best possible outcomes.
Not every elevated PSA requires a biopsy. We use advanced screening tools—including prostate MRI, genetic testing, and individualized risk assessment—to determine who may benefit from further evaluation, helping improve detection while reducing unnecessary procedures.
A transperineal prostate biopsy is the most advanced method for diagnosing prostate cancer. Performed through the skin rather than the rectum, it offers significantly lower infection risk and greater diagnostic accuracy than traditional biopsy techniques. In addition, we incorporate MRI fusion guided approach for even further accuracy in diagnosing prostate cancer.
We offer leading-edge treatment options, including brachytherapy, focal brachytherapy, rectal spacing, and theranostics. Every treatment plan is tailored to the individual with a focus on effective cancer control while preserving quality of life.
We place people over profit to drive radical change in the treatment of prostate cancer using the most advanced techniques in prostate brachytherapy that give the best outcomes to patients.
Prostate Cancer Institute of America was founded in 2022 and is the only practice in the United States exclusively dedicated to providing LDR-B services.
To provide LDR Prostate Brachytherapy services to communities across the nation in a collaborative manner with our colleagues and peers in the Urology space.
Contact Prostate Cancer Institute of America to discover if this therapy is right for you.
Seeds are implanted in the prostate gland to kill cancer at its source, minimizing damage to nearby healthy tissue.
The approximate one-hour procedure yields high cure rates with minimal side effects.
We only practice evidence-based medicine while giving the best treatment available.
LDR brachytherapy has shown to have the best rates of erectile function preservation.
The choice between LDR prostate brachytherapy and surgery depends on various factors, including the patient’s health, the stage of the cancer, and individual preferences. Each option has its own advantages and disadvantages.
LDR prostate brachytherapy may be preferred over surgery because it is:
Minimally Invasive Procedure: LDR brachytherapy is a minimally invasive procedure, involving the placement of radioactive seeds directly into the prostate gland, targeting the cancer cells while minimizing damage to surrounding healthy tissues.
Shorter Recovery Time: Patients undergoing LDR brachytherapy may experience a quicker recovery time compared to those undergoing surgery. In fact, most men can resume normal activity the following day.
Lower Risk of Certain Side Effects: LDR brachytherapy is associated with a lower risk of certain side effects, including blood loss, infection and urinary incontinence.
Outpatient Procedure: LDR brachytherapy is performed on an outpatient basis—patients go home on the same day as the procedure. Surgery, especially radical prostatectomy, typically requires a hospital stay.
Potential for Preserving Sexual Function: LDR brachytherapy may have a lower risk of causing erectile dysfunction compared to surgery, although individual experiences can vary.
Our mission is to combine cutting-edge technology, business acumen, compassionate care and clinical expertise to drive radical change in the treatment of prostate cancer through low dose rate prostate brachytherapy.
Modern Low Dose Rate Brachytherapy For Prostate Cancer: A Comprehensive Guide for Urologists
We accept most insurance providers. If you have specific questions regarding your coverage, please contact us for additional information.